D-0570-2024 Class II
FDA drug recall D-0570-2024 was initiated by Medisca Inc. on Jun 26, 2024 and is designated Class II. Reason for recall: CGMP Deviations and Presence of Particulate Matter: Glass Affected quantity: 113 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 10, 2024
- Initiation Date
- Jun 26, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 113 bottles
Product description
Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 38779-3097-00.
Reason for recall
CGMP Deviations and Presence of Particulate Matter: Glass
Distribution pattern
Nationwide in the USA and Canada
Code information
Lot #s: 202323/G, 202323/H, Exp. 07/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0570-2024
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026